335 related articles for article (PubMed ID: 8231650)
21. Kininogen and kinin in experimental spinal cord injury.
Xu J; Hsu CY; Junker H; Chao S; Hogan EL; Chao J
J Neurochem; 1991 Sep; 57(3):975-80. PubMed ID: 1861161
[TBL] [Abstract][Full Text] [Related]
22. Characterization of human salivary kallikrein: reactivities to human plasma kininogens and proteinase inhibitors.
Sakamoto W; Yoshikawa K; Uehara S; Nishikaze O
J Biochem; 1983 Mar; 93(3):833-8. PubMed ID: 6553577
[TBL] [Abstract][Full Text] [Related]
23. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein.
El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F
Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709
[TBL] [Abstract][Full Text] [Related]
24. Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein.
Wiggins RC
J Biol Chem; 1983 Jul; 258(14):8963-70. PubMed ID: 6553057
[TBL] [Abstract][Full Text] [Related]
25. Canine plasma kininogen: evidence for the presence of two kininogens and purification of high molecular weight kininogen and characterization as multi-functional molecule.
Mashiko H; Takahashi H
Comp Biochem Physiol B Biochem Mol Biol; 1997 Aug; 117(4):535-43. PubMed ID: 9297798
[TBL] [Abstract][Full Text] [Related]
26. The role of kinin B1 in the plasma extravasation of carrageenin-induced pleurisy.
Hayashi I; Amano H; Ishihara K; Kumagai Y; Yoshimura H; Majima MC
Life Sci; 2002 Jan; 70(8):937-49. PubMed ID: 11853231
[TBL] [Abstract][Full Text] [Related]
27. Cleavage of porcine high molecular weight kininogen by the action of porcine pancreatic kallikrein.
Mashiko H; Miyamoto K; Takahashi H
Immunopharmacology; 1999 Dec; 45(1-3):103-5. PubMed ID: 10614997
[TBL] [Abstract][Full Text] [Related]
28. A mechanism for hereditary angioedema caused by a methionine-379-to-lysine substitution in kininogens.
Dickeson SK; Kumar S; Sun MF; Litvak M; He TZ; Phillips DR; Roberts ET; Feener EP; Law RHP; Gailani D
Blood; 2024 Feb; 143(7):641-650. PubMed ID: 37992228
[TBL] [Abstract][Full Text] [Related]
29. Comparison of human high molecular weight kininogen digestion by plasma kallikrein and by plasmin. A revised method of purification of high molecular weight kininogen.
Kleniewski J; Donaldson VH
J Lab Clin Med; 1987 Apr; 109(4):469-79. PubMed ID: 2950194
[TBL] [Abstract][Full Text] [Related]
30. Purification and characterization of rat low molecular weight kininogen.
Sakamoto W; Yoshikawa K; Uehara S; Nishikaze O; Handa H
J Biochem; 1984 Jul; 96(1):81-8. PubMed ID: 6238024
[TBL] [Abstract][Full Text] [Related]
31. T-kininogenase activity of the rat submandibular gland is predominantly due to the kallikrein-like serine protease antigen gamma.
Berg T; Wassdal I; Mindroiu T; Sletten K; Scicli G; Carretero OA; Scicli AG
Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):19-25. PubMed ID: 1741746
[TBL] [Abstract][Full Text] [Related]
32. Studies on human high molecular weight (HMW) kininogen. III. Cleavage of HMW kininogen by the action of human salivary kallikrein.
Mori K; Sakamoto W; Nagasawa S
J Biochem; 1981 Aug; 90(2):503-9. PubMed ID: 6913579
[TBL] [Abstract][Full Text] [Related]
33. Bradykinin release from high molecular weight kininogen and increase in plasma kallikrein-like activity following sensory stimulation by food in the rat.
Rothschild AM; Gomes EL; Fortunato IC
Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):483-8. PubMed ID: 9826071
[TBL] [Abstract][Full Text] [Related]
34. Characterization of serine proteinases isolated from rat submaxillary gland: with special reference to the degradation of rat kininogens by these enzymes.
Kato H; Nakanishi E; Enjyoji K; Hayashi I; Oh-ishi S; Iwanaga S
J Biochem; 1987 Dec; 102(6):1389-404. PubMed ID: 3482210
[TBL] [Abstract][Full Text] [Related]
35. Generation of vasoactive peptide bradykinin from human umbilical vein endothelium-bound high molecular weight kininogen by plasma kallikrein.
Nishikawa K; Shibayama Y; Kuna P; Calcaterra E; Kaplan AP; Reddigari SR
Blood; 1992 Oct; 80(8):1980-8. PubMed ID: 1391955
[TBL] [Abstract][Full Text] [Related]
36. Role of high molecular weight (HMW)-kininogen in inflammatory exudation: evidence with the studies of the HMW-kininogen deficient rat.
Oh-ishi S; Hayashi I; Yamaki K; Utsunomiya I; Hayashi M; Yamasu A; Nakano T
Adv Exp Med Biol; 1989; 247A():145-52. PubMed ID: 2690585
[TBL] [Abstract][Full Text] [Related]
37. High concentrations of free kinins and kinin system components in abdominal transudate of a patient with nephrotic syndrome.
Paskhina TS; Polyantseva LR; Krinskaya AV; Yegorova TP; Nartikova VP; Levina GO
Clin Chim Acta; 1979 Sep; 97(1):73-82. PubMed ID: 227622
[TBL] [Abstract][Full Text] [Related]
38. Bradykinin regulates the expression of kininogen binding sites on endothelial cells.
Zini JM; Schmaier AH; Cines DB
Blood; 1993 Jun; 81(11):2936-46. PubMed ID: 8388750
[TBL] [Abstract][Full Text] [Related]
39. Demonstration of derivation of rat urinary bradykinin from plasma low-molecular-weight kininogen: a study using kininogen-deficient rats.
Hagiwara Y; Kojima M; Hayashi I; Oh-ishi S
Biochem Biophys Res Commun; 1994 Nov; 204(3):1219-24. PubMed ID: 7980599
[TBL] [Abstract][Full Text] [Related]
40. Effects of an orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy.
Majima M; Kawashima N; Hiroshi I; Katori M
Br J Pharmacol; 1997 Jun; 121(4):723-30. PubMed ID: 9208140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
